Peer Exchange

Expert dermatologists discuss diagnosis and treatment of prurigo nodularis (PN). They review data for the only FDA-approved treatment for prurigo nodularis and the implications of the results in management of the disease.

Rheumatology specialists discuss challenges in the management of rheumatoid arthritis (RA), and how the trial-and-error approach to treatment selection and continued use of ineffective treatments impacts quality of life in RA. The panel discusses tools available to guide treatment selection and how personalization of care can improve treatment outcomes.

Experts gastroenterologists share insights on optimizing the management of Crohn’s disease, focusing on the current treatment landscape and the role of biologic therapy.

Retina specialists discuss clinical burden of geography atrophy, its current management, data with emerging treatment options, and the promise newer therapies might offer for treatment of geographic atrophy.

In this upcoming HCPLive program, experts review available and emerging treatment options for the management of plaque psoriasis, highlighting recent approvals and long-term safety and efficacy data.

Key opinion leaders discuss management of attention deficit hyperactivity disorder (ADHD) in pediatric and adult population and how the emerging data are likely to influence treatment of ADHD in adult patients going forward.

Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.

Experts in cardiology discuss the management of hypercholesterolemia and atherosclerotic cardiovascular diseases (ASCVD), the importance of achieving LDL-C lowering goals, and treatment of hypercholesterolemia in patients who are statin-intolerant.

An expert cardiologist, sleep specialist, and pulmonologist, share insights on the awareness and treatment of sleep disorders, including insomnia, that co-occur with other health conditions.

Experts in dermatology provide an overview of pediatric atopic dermatitis and take a deep dive into the management of this condition highlighting recent treatment advances.

Experts in blood disorders share the importance of managing red blood cell health and optimal approaches and unmet needs in the management of sickle cell disease.

Experts in dermatology discuss treatment considerations for pediatric patients with atopic dermatitis and highlight emerging therapeutics andthe role they are likely to play in the future treatment of this condition.

Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.

A multidisciplinary panel of experts explores recent advances in the management of opioid induced constipation.

Retina specialists explore the practical and clinical implications of the rapidly developing treatment spectrum for diabetic macular edema and age-related macular degeneration.

Experts in pediatric hepatology share considerations for the diagnosis of Alagille syndrome and explore strategies for optimizing treatment.

Expert gastroenterologists examine the sequencing of therapies and optimizing treatment selection in the evolving treatment landscape for ulcerative colitis.

Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.

Experts in endocrinology and cardiology discuss various guideline and treatments for the management of ASCVD and hypercholesterolemia.

A panel of experts discusses vitiligo, its impact on the quality of life, and the role of shared-decision making in managing the disease. Panelists discuss their approach to setting patient expectations and share their enthusiasm about ongoing vitiligo research and therapies on the horizon.

A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.

Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.

A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.

Expert panelists reflect on the selection and use of recently approved treatments, including interleukin pathway inhibitors, for type 2 inflammation in atopic dermatitis.

A panel of experts explore the impact of sickle cell disease on patients and discuss treatment and management considerations.

A panel of experts discuss their knowledge and experiences treating patients with psoriatic arthritis.

A panel of eye care specialists provide insight on the diagnosis, clinical manifestations, and treatment options for patients who have wet AMD.